SBI Life is quite optimistic about a rebound in premiums led by a combination of cross-sell by SBI, penetration into new bank partners' clients and new product launches. It also sees scope for expansion in margins with better product mix & cost controls. SBI Life's targeted client base can have overlaps with LIC's target segment and that would need to be watched. Jefferies see 20% VNB CAGR over FY21-23 and ROEV of 17%. Jefferies maintains Buy rating on SBI Life with a price target of Rs 1110. SBI Life share price closed yesterday at Rs 923.85, up Rs 20 or 2.25%.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

SBI Life seems quite optimistic about premium momentum for FY21 and FY22 with a combination of:

(1) increased cross-sells by SBI which drove 60% + of their premiums in 9M FY21
(2) increasing penetration into new PSU bank partnerships
(3) launch of new products on non-Par as well as annuity side.

See Zee Business Live TV Streaming Below:

In the ULIP segment, SBI Life should be less affected by changes in tax laws as its ticket size of premiums was lower than the industry average with a higher share of the debt-segment. Margins can also expand with increasing share of pure protection over return of premium products (from 10-15% of retail protection to 25-30%). There should be scope for further expansion in margins aided by a rising share of pure protection (vs. ROPs) and some cost efficiencies.

New partnerships offer growth prospects; higher overlap with LIC's targeted customers. The key opportunity for SBI Life is to deepen its partnership with non-SBI PSU banks like Uco Bank, Indian Bank/ Allahabad Bank and Private lender South Indian Bank, which together drive just around 2-3% of the retail APE and management sees scope for stronger growth. It has also recently forged a bancassurance partnership with Yes Bank - this should reflect in growth for FY22 onwards. Jefferies will watch for any impact of aggressive sales push by LIC, which may have higher overlap with the targeted segments and markets of SBI Life.

SBI Life remains a strong play on the growth runway afforded by SBI's client base (till date <2% of SBI customer pool has been tapped). We roll-forward our price target to Rs1,110 (from 1,080) based on 2.7x Mar-23 P/EV and maintain our Buy rating><2% of SBI customer pool has been tapped). Jefferies roll-forward our price target to Rs 1110 (from Rs 1080) based on 2.7x Mar-23 P/EV and maintain their Buy rating.